ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies

By  

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2272-2281

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-4, Interleukin-8 and E-selectin Levels in Intranasal Polyposis Patients with and without Allergy: a Comparative Study

By Ural A   Tezer MS   Yücel A   Atilla H   İleri F  

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 520-524

Field House Publishing

Access to resources Recommend Favorite

Macrolides Allergy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 27, 2008-09 ,pp. : 2840-2862

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-CD4 monoclonal antibody/tumour necrosis factor α inhibitors: Cytokine release syndromes, allergy, CD4+ T-cell lymphopenia and maculopapular rash: 8 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Genotoxicity of 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido[2,3-e][1,2,4] triazolo[4,3-a]pyrazine, a Potent H4 Receptor Antagonist for the Treatment of Allergy: Evidence of Glyoxal Intermediate Involvement

By  

Drug Metabolism Letters, Vol. 11, Iss. 2, 2018-02 ,pp. : 144-148

Bentham Science Publishers

Access to resources Recommend Favorite